SCYNEXIS, Inc. Temporary Equity, Liquidation Preference
SCYNEXIS, Inc. (SCYX) had Temporary Equity, Liquidation Preference of $88.79 million as of 2014-03-31, per its 10-Q/A filed 2014-07-11.
Discontinued › Balance Sheet › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2014-07-11
- 2014-03-31: Temporary Equity, Liquidation Preference $88.79M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2014-03-31 | $88.79M 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |